Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
Condition: Leiomyosarcoma Intervention: Drug: Temozolomide for injection combined with epirubicin Sponsor: Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2022 Category: Research Source Type: clinical trials
Niraparib for the Treatment of Leiomyosarcoma
Conditions: Locally Advanced Leiomyosarcoma; Metastatic Leiomyosarcoma; Stage III Retroperitoneal Sarcoma AJCC v8; Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IIIA Retroperitoneal Sarcoma AJCC v8; Stage IIIA Soft Tissue Sarcoma of the Trunk and Extre mities AJCC v8; Stage IIIB Retroperitoneal Sarcoma AJCC v8; Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IV Retroperitoneal Sarcoma AJCC v8; Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Unresectable Leiomyosarcoma Intervention: Drug: Ni...
Source: ClinicalTrials.gov - December 30, 2021 Category: Research Source Type: clinical trials
Nanatinostat Plus Valganciclovir in Patients With Advanced EBV+ Solid Tumors, and in Combination With Pembrolizumab in EBV+ RM-NPC
Conditions: Nasopharyngeal Carcinoma; EBV-Related Gastric Carcinoma; EBV-Related Leiomyosarcoma; EBV Related Carcinoma; EBV-Related Sarcoma Interventions: Drug: Nanatinostat; Drug: Pembrolizumab; Drug: Valganciclovir Sponsor: Viracta Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2021 Category: Research Source Type: clinical trials
